Ocugen (OCGN) Assets Average (2015 - 2026)
Ocugen (OCGN) reported Assets Average of $50.2 million for Q1 2026, down 31.64% on a YoY basis from $73.5 million in Q1 2025, and down 0.68% quarter-over-quarter from $50.6 million in Q4 2025.
Ocugen (OCGN) Assets Average (2015 - 2026) Analysis & Trends
Ocugen has reported Assets Average for 12 years, with the latest figure at $50.2 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 31.64% year-over-year to $50.2 million; the trailing twelve-month figure through Mar 2026 stood at $50.2 million (down 31.64% YoY), and the FY2025 full-year result was $63.0 million, down 14.31% from the prior year.
- Assets Average for Q1 2026 stood at $50.2 million, down from $50.6 million in the prior quarter.
- The five-year high for Assets Average was $135.9 million in Q2 2022, with the low at $46.2 million in Q2 2024.
- Historically, Assets Average has averaged $79.9 million across 5 years, with a median of $72.2 million in 2024.
- Annual changes were most pronounced in 2022 — Assets Average surged 204.7% — and 2024, when it tumbled 50.16%.
- Ocugen's Assets Average stood at $112.4 million in 2022, then sank by 38.08% to $69.6 million in 2023, then grew by 3.69% to $72.2 million in 2024, then declined by 29.97% to $50.6 million in 2025, then retreated by 0.68% to $50.2 million in 2026.
- The last three Assets Average figures came in at $50.2 million (Q1 2026), $50.6 million (Q4 2025), and $55.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | 50.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.21 Mn |
| Dec 31, 2025 | 50.56 Mn |
| Sep 30, 2025 | 55.60 Mn |
| Jun 30, 2025 | 59.03 Mn |
| Mar 31, 2025 | 73.45 Mn |
| Dec 31, 2024 | 72.19 Mn |
| Sep 30, 2024 | 51.24 Mn |
| Jun 30, 2024 | 46.17 Mn |
| Mar 31, 2024 | 58.17 Mn |
| Dec 31, 2023 | 69.62 Mn |
| Sep 30, 2023 | 81.83 Mn |
| Jun 30, 2023 | 92.64 Mn |
| Mar 31, 2023 | 102.47 Mn |
| Dec 31, 2022 | 112.44 Mn |
| Sep 30, 2022 | 123.16 Mn |
| Jun 30, 2022 | 135.91 Mn |
| Mar 31, 2022 | 123.74 Mn |
| Dec 31, 2021 | 111.04 Mn |
| Sep 30, 2021 | 120.28 Mn |
| Jun 30, 2021 | 89.05 Mn |